[ad_1] Herpen, the Netherlands-based Orexa, a clinical-stage pharmaceutical firm, introduced on Wednesday, January 31, that it has secured €870K from…
Browsing: Therapeutics
[ad_1] Flex Level Safety Aquestive Therapeutics (NASDAQ:AQST) is rapidly approaching a key topline knowledge readout for the Anaphylm (epinephrine) sublingual…
[ad_1] Dr_Microbe/iStock through Getty Photos Corcept Therapeutics (NASDAQ:CORT) plummeted 38% in after-hours buying and selling on Friday after a loss…
[ad_1] Pharma main Solar Pharmaceutical on Monday knowledgeable that it has entered into an settlement to accumulate 16.7 per cent…
[ad_1] Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY)…
[ad_1] JHVEPhoto/iStock Editorial by way of Getty Photos Amgen (NASDAQ:AMGN) mentioned that the Federal Commerce Fee’s lawsuit to problem its…
[ad_1] Andrey Tolkachev Oncology drug developer Depth Therapeutics (NASDAQ:INTS) has upsized its proposed preliminary public providing to $15M from $8M.…
[ad_1] Picture credit: Aer TherapeuticsAer Therapeutics, a biopharmaceutical spin-out firm and a collaboration between College School Dublin (UCD) and the…
[ad_1] Marvell Expertise GroupSupply: marvell.comTake a look at the businesses making headlines earlier than the bell:Marvell Expertise (MRVL) – The…
[ad_1] 2nd illustrations and pictures Malaysian biotech CytoMed Therapeutics (GDTC) has filed for a proposed $15M preliminary public providing. CytoMed…